Pictet Asset Management Holding Sa Neurocrine Biosciences Inc Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 696,122 shares of NBIX stock, worth $89.7 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
696,122
Previous 387,574
79.61%
Holding current value
$89.7 Million
Previous $42.9 Million
104.12%
% of portfolio
0.09%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
645Shares Held
96.8MCall Options Held
743KPut Options Held
508K-
Black Rock Inc. New York, NY14.2MShares$1.83 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$713 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$627 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$344 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...